Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

RSV Antikörper

Der Kaninchen Polyklonal anti-RSV Antikörper wird verwendet zum Nachweis von RSV in Proben von Respiratory Syncytial Virus (RSV). Er wurde validiert für WB.
Produktnummer ABIN437960
449,63 €
Zzgl. Versandkosten 20,00 € und MwSt
0.1 mL
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für RSV Antikörper (ABIN437960)

Target

RSV (Respiratory Syncytial Virus (RSV))

Reaktivität

  • 70
  • 13
  • 13
  • 13
Respiratory Syncytial Virus (RSV)

Wirt

  • 40
  • 25
  • 20
Kaninchen

Klonalität

  • 40
  • 39
Polyklonal

Konjugat

  • 42
  • 12
  • 9
  • 7
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser RSV Antikörper ist unkonjugiert

Applikation

  • 42
  • 24
  • 23
  • 20
  • 13
  • 13
  • 11
  • 10
  • 8
  • 8
  • 8
  • 6
  • 5
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)
  • Aufreinigung

    Aff - Purified

    Immunogen

    Whole RSV virions (subgroup A-Long strain) were used as an immunogen. Detects G, F, N and M2 proteins of RSV.

    Isotyp

    IgG
  • Applikationshinweise

    Optimal working dilutions should be determined experimentally by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Lagerung

    -20 °C
  • Target

    RSV (Respiratory Syncytial Virus (RSV))

    Substanzklasse

    Virus

    Hintergrund

    RSV is a negative sense RNA paramyxovirus in which the major virus neutralization antigens are the glycoprotein (G) and the fusion (F) protein that mediate attachment and fusion to the host cell during virus infection, respectively. Other RSV proteins include the nucleocapsid protein (N) and the M2 protein. The two major subgroups of RSV are A and B with the A strain being more virulent and responsible for the majority of severe RSV infections. Respiratory syncytial virus (RSV) infection is responsible for a large proportion of viral respiratory infections, and significant morbidity is associated with RSV infections. To date, few RSV vaccine candidates have shown promise with no human vaccine yet been proven safe and efficacious.
Sie sind hier:
Chat with us!